Financial statements Biogened
Balance sheet of Biogened
Company age:
Age:
18 y. 10 m. 9 d.
Share capital:
Share capital:
7 415 300 PLN
Balance sheet data of BIOGENED
|
Year
|
2018
|
2019
|
2021
|
2023
|
|---|---|---|---|---|
| Total assets | 82 597 635,24 | 84 691 447,27 | 61 015 161,14 | 78 510 569,35 |
| A. Fixed assets | 39 271 242,99 | 38 499 336,18 | 21 511 623,67 | 34 674 652,01 |
| B. Current assets | 43 326 392,25 | 46 192 111,09 | 39 503 537,47 | 43 835 917,34 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 | 0,00 |
| D. Own shares (stocks) | 0,00 | 0,00 | 0,00 | 0,00 |
| Total liabilities | 82 597 635,24 | 84 691 447,27 | 61 015 161,14 | 78 510 569,35 |
| A. Equity | 52 708 124,12 | 53 979 778,66 | 29 948 811,73 | 36 707 780,07 |
| B. Liabilities and provisions for liabilities | 29 889 511,12 | 30 711 668,61 | 31 066 349,41 | 41 802 789,28 |
| I. Long-term liabilities | 7 643 662,71 | 5 856 334,97 | 7 241 609,97 | 9 539 920,05 |
| II. Short-term liabilities | 20 560 684,94 | 22 901 897,62 | 22 111 105,07 | 30 634 871,09 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.